US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist
  • 0.295
  • -0.019-6.09%
Close Mar 18 16:00 ET
  • 0.292
  • -0.003-0.92%
Post 20:01 ET
50.24MMarket Cap-3.68P/E (TTM)

About X4 Pharmaceuticals Company

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

Company Profile

SymbolXFOR
Company NameX4 Pharmaceuticals
Listing DateNov 16, 2017
Issue Price10.00
Founded2010
CEODr. Paula S. Ragan, PhD
MarketNASDAQ
Employees93
Fiscal Year Ends12-31
Address61 North Beacon Street,4th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02134
Phone1-857-529-8300
Websitehttp://www.x4pharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Paula S. Ragan, PhD
  • Director, President and Chief Executive Officer
  • 2.04M
  • Christophe Arbet-Engels
  • Chief Medical Officer
  • 1.64M
  • Adam S. Mostafa
  • Chief Financial Officer, Principal Accounting Officer, Treasurer and Corporate Secretary
  • 1.15M
  • Dr. Mary DiBiase, PhD
  • Chief Operating Officer
  • --
  • Arthur Taveras
  • Chief Scientific Officer
  • --
  • Mark Baldy
  • Chief Commercial Officer
  • --
  • Michael Stephen Wyzga
  • Chairman of the Board
  • 199.34K
  • Dr. Gary J. Bridger, PhD
  • Director
  • 147.05K
  • Dr. Murray W. Stewart, M.D.
  • Director
  • 90.08K
  • David W.J. McGirr, M.B.A.
  • Independent Director
  • 166.05K
  • Francoise de Craecker
  • Independent Director
  • 152.05K
  • Alison F. Lawton
  • Independent Director
  • 154.55K
  • Robert Keith Woods
  • Independent Director
  • 91.83K
  • William E. Aliski
  • Independent Director
  • 165.05K

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Dorian LPG
LPG
22.520
YETI Holdings
YETI
34.180
Workday
WDAY
251.910
4
Collegium Pharmaceutical
COLL
29.820
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.010
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.